Zoetis Other developed markets — Revenue decreased by 7.1% to $169.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 27.1%, from $133.00M to $169.00M. Over 4 years (FY 2021 to FY 2025), Other developed markets — Revenue shows an upward trend with a 8.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates successful market penetration, strong product demand, or favorable pricing power in these developed regions, while a decrease may signal competitive pressure or economic headwinds in those specific territories.
This metric represents the total net sales generated from the company's operations within developed geographic regions o...
Peers in the animal health or pharmaceutical sectors typically report similar geographic revenue splits, often categorized as 'Rest of World' or specific regional groupings like 'EMEA' or 'APAC' developed markets.
zts_segment_other_developed_markets_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $112.00M | $127.00M | $117.00M | $115.00M | $118.00M | $121.00M | $114.00M | $122.00M | $125.00M | $127.00M | $138.00M | $127.00M | $138.00M | $148.00M | $151.00M | $133.00M | $162.00M | $164.00M | $182.00M | $169.00M |
| QoQ Change | — | +13.4% | -7.9% | -1.7% | +2.6% | +2.5% | -5.8% | +7.0% | +2.5% | +1.6% | +8.7% | -8.0% | +8.7% | +7.2% | +2.0% | -11.9% | +21.8% | +1.2% | +11.0% | -7.1% |
| YoY Change | — | — | — | — | +5.4% | -4.7% | -2.6% | +6.1% | +5.9% | +5.0% | +21.1% | +4.1% | +10.4% | +16.5% | +9.4% | +4.7% | +17.4% | +10.8% | +20.5% | +27.1% |